OpGen provides update on Curetis Group’s R&D collaboration
OpGen announced that its wholly-owned subsidiary Ares Genetics has entered into a multi-phase collaboration with an undisclosed leading global in vitro diagnostics corporation to jointly develop diagnostic solutions for infectious disease testing based on NGS technology. September 18, 2019